| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | ibrutinib | CTRPv2 | pan-cancer | AAC | 0.069 | 0.1 |
| mRNA | Vandetanib | CCLE | pan-cancer | AAC | 0.074 | 0.1 |
| mRNA | PHA-665752 | CCLE | pan-cancer | AAC | -0.074 | 0.1 |
| mRNA | phloretin | CTRPv2 | pan-cancer | AAC | 0.056 | 0.1 |
| mRNA | AZD6244 | CCLE | pan-cancer | AAC | 0.069 | 0.1 |
| mRNA | LRRK2-IN-1 | CTRPv2 | pan-cancer | AAC | -0.06 | 0.1 |
| mRNA | cediranib | CTRPv2 | pan-cancer | AAC | -0.087 | 0.1 |
| mRNA | BRD1835 | CTRPv2 | pan-cancer | AAC | 0.061 | 0.1 |
| mRNA | vincristine | CTRPv2 | pan-cancer | AAC | 0.049 | 0.1 |
| mRNA | PRIMA-1-Met | CTRPv2 | pan-cancer | AAC | -0.087 | 0.1 |